Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs)

Medicine & Life Sciences

• Autoantibodies 16%
• CD40 Ligand 11%
• Chronic Granulomatous Disease 24%
• Dendritic Cells 16%
• DiGeorge Syndrome 12%
• Ectodermal Dysplasia 12%
• Hyper-IgM Immunodeficiency Syndrome 15%
• Immunoglobulin E 16%
• Infections 21%
• Innate Immunity 8%
• interferon regulatory factor-8 15%
• Interleukin-12 18%
• Interleukin-12 Subunit p40 13%
• Macrophages 6%
• Monocytes 7%
• Mutation 10%
• Mycobacterium 9%
• Mycobacterium tuberculosis 8%
• Natural Killer Cells 8%
• Nontuberculous Mycobacteria 11%
• Nontuberculous Mycobacterium Infections 13%
• Phenotype 16%
• Primary Immunodeficiency Diseases 100%
• Proteolysis 8%
• Salmonella 9%
• Salmonella Infections 11%
• Severe Combined Immunodeficiency 23%
• T-Lymphocytes 5%
• Type 1 Hyper-IgM Immunodeficiency Syndrome 16%
• Vacuoles 9%
• Virulence 7%